Paper Details

  1. Home
  2. Paper Details

Beta-blockers and heart failure.

Author: CruickshankJohn M

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review discusses the use of beta-blockers (BB) in the treatment of heart failure (HF). BB are effective in treating systolic HF, reducing all-cause death by 34-5%. Bisoprolol, metoprolol, and carvedilol are considered the most effective BB for treating systolic HF. The choice of BB is important, as benefit is not a class-effect. Adverse effects are mainly associated with beta-2 blockade and alpha-blockade.
Paper Details　
Original Abstract of the Article :
The life-time risk of developing HF is about 20% (40% if hypertension present). With increasing longevity in the developed world the burden of HF (hospitalisation) is set to increase over the next 10-20 years. CAD and hypertension are the two main causes of HF; CAD (and obesity) in the case of systo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/21180298

データ提供：米国国立医学図書館（NLM）

Beta-Blockers: A Vital Tool in the Fight Against Heart Failure

This research delves into the intriguing world of beta-blockers and their role in managing heart failure (HF), a condition affecting millions worldwide. The study explores the mechanisms behind beta-blockers' efficacy in treating HF, particularly systolic HF, and examines the potential benefits and risks associated with their use. The authors highlight the importance of choosing the right beta-blocker for each patient, considering their individual needs and potential adverse reactions.

A Powerful Ally in Heart Health

The study emphasizes the crucial role of beta-blockers, alongside ACE inhibitors, in the treatment of systolic HF. The authors highlight the significant reduction in all-cause death, ranging from 34-5%, achieved through the use of beta-blockers like bisoprolol, metoprolol, and carvedilol. This remarkable effect underscores the potential of beta-blockers in improving patient outcomes and extending lives.

Navigating the Desert of Heart Failure

This research provides valuable insights into the management of heart failure, emphasizing the importance of personalized treatment strategies. While beta-blockers offer significant benefits, it's crucial to understand their potential side effects and choose the right medication for each individual. Just as a camel navigates the harsh desert landscape, we must carefully consider the terrain of heart health, adjusting our course to ensure a safe and effective journey for each patient.

Dr. Camel's Conclusion

The study sheds light on the intricate interplay between beta-blockers and heart health, highlighting their potential to improve patient outcomes. However, just as a wise camel navigates the desert with caution and awareness, we must approach beta-blocker therapy with a thoughtful and informed approach, considering the individual needs and risks involved. This research serves as a valuable guide in our quest to conquer the challenges of heart failure, offering hope and knowledge along the way.

Date :
  1. Date Completed 2011-02-24
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

21180298

DOI: Digital Object Identifier

21180298

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.